180 related articles for article (PubMed ID: 37573025)
21. Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.
Lee YJ; Lee SW; Kim KR; Jung KH; Lee JW; Kim YM
J Gynecol Oncol; 2017 Jan; 28(1):e3. PubMed ID: 27670257
[TBL] [Abstract][Full Text] [Related]
22. High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of
Stroot IAS; Brouwer J; Bart J; Hollema H; Stommel-Jenner DJ; Wagner MM; van Doorn HC; de Hullu JA; Gaarenstroom KN; Beurden M; van Lonkhuijzen LRCW; Slangen BFM; Zweemer RP; Gómez Garcia EB; Ausems MGEM; Boere IA; van Engelen K; van Asperen CJ; Schmidt MK; Wevers MR; de Bock GH; Mourits MJE;
J Clin Oncol; 2023 May; 41(14):2523-2535. PubMed ID: 36809028
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Wethington SL; Park KJ; Soslow RA; Kauff ND; Brown CL; Dao F; Otegbeye E; Sonoda Y; Abu-Rustum NR; Barakat RR; Levine DA; Gardner GJ
Int J Gynecol Cancer; 2013 Nov; 23(9):1603-11. PubMed ID: 24172097
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
Cortesi L; De Matteis E; Toss A; Marchi I; Medici V; Contu G; Xholli A; Grandi G; Cagnacci A; Federico M
Oncology; 2017; 93(6):377-386. PubMed ID: 28848147
[TBL] [Abstract][Full Text] [Related]
25. Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Reitsma W; de Bock GH; Oosterwijk JC; Bart J; Hollema H; Mourits MJ
Eur J Cancer; 2013 Jan; 49(1):132-41. PubMed ID: 22921157
[TBL] [Abstract][Full Text] [Related]
26. The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
Rudaitis V; Mikliusas V; Januska G; Jukna P; Mickys U; Janavicius R
Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():26-31. PubMed ID: 32059136
[TBL] [Abstract][Full Text] [Related]
27. Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.
Ishikawa H; Kiyokawa T; Utsuno E; Matsushita K; Nomura F; Shozu M
Jpn J Clin Oncol; 2014 Jun; 44(6):597-601. PubMed ID: 24719479
[TBL] [Abstract][Full Text] [Related]
28. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.
Rabban JT; Krasik E; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Dec; 33(12):1878-85. PubMed ID: 19898224
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.
Chay WY; McCluggage WG; Lee CH; Köbel M; Irving J; Millar J; Gilks CB; Tinker AV
Int J Gynecol Cancer; 2016 Mar; 26(3):431-6. PubMed ID: 26807643
[TBL] [Abstract][Full Text] [Related]
30. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
31. Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report.
Grandi G; Caroli M; Alboni C; Cortesi L; Toss A; Barbieri E; Botticelli L; Facchinetti F
Fam Cancer; 2020 Oct; 19(4):291-295. PubMed ID: 32328861
[TBL] [Abstract][Full Text] [Related]
32. Serous tubal intraepithelial carcinoma arising from the intrauterine portion of the fallopian tube after bilateral salpingo-oophorectomy.
Yoshida H; Shintani D; Imai Y; Fujiwara K
Eur J Gynaecol Oncol; 2016; 37(3):404-6. PubMed ID: 27352575
[TBL] [Abstract][Full Text] [Related]
33. The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review.
Blok F; Roes EM; van Leenders GJ; van Beekhuizen HJ
BMC Cancer; 2016 Jan; 16():18. PubMed ID: 26768420
[TBL] [Abstract][Full Text] [Related]
34. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.
Powell CB; Chen LM; McLennan J; Crawford B; Zaloudek C; Rabban JT; Moore DH; Ziegler J
Int J Gynecol Cancer; 2011 Jul; 21(5):846-51. PubMed ID: 21670699
[TBL] [Abstract][Full Text] [Related]
35. Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer.
Feng Z; Zuo K; Ju X; Chen X; Yang W; Wen H; Yu L; Wu X
J Ovarian Res; 2023 Jun; 16(1):125. PubMed ID: 37386498
[TBL] [Abstract][Full Text] [Related]
36. Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline
Lim H; Kim SI; Hyun S; Lee GB; Seol A; Lee M
Yonsei Med J; 2021 Dec; 62(12):1090-1097. PubMed ID: 34816639
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.
Harmsen MG; Piek JMJ; Bulten J; Casey MJ; Rebbeck TR; Mourits MJ; Greene MH; Slangen BFM; van Beurden M; Massuger LFAG; Hoogerbrugge N; de Hullu JA
Cancer; 2018 Mar; 124(5):952-959. PubMed ID: 29315498
[TBL] [Abstract][Full Text] [Related]
38.
Akahane T; Masuda K; Hirasawa A; Kobayashi Y; Ueki A; Kawaida M; Misu K; Nakamura K; Nagai S; Chiyoda T; Yamagami W; Hayashi S; Kataoka F; Banno K; Sugano K; Okita H; Kosaki K; Nishihara H; Aoki D
J Gynecol Oncol; 2022 Jul; 33(4):e50. PubMed ID: 35557033
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
Olivier RI; van Beurden M; Lubsen MA; Rookus MA; Mooij TM; van de Vijver MJ; van't Veer LJ
Br J Cancer; 2004 Apr; 90(8):1492-7. PubMed ID: 15083174
[TBL] [Abstract][Full Text] [Related]
40. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
